Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation

Cancer Research

Volumn 63, Issue 3, 2003, Pages 674-681

  Suzuki, Akira ^a   Itami, Satoshi ^c   Ohishi, Minako ^b   Hamada, Koichi ^a   Inoue, Tae ^a   Komazawa, Nobuyasu ^c   Senoo, Haruki ^a   Sasaki, Takehiko ^d   Takeda, Junji ^c   Manabe, Motomu ^a   Mak, Tak Wah ^e,f   Nakano, Toru ^b  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e UNIVERSITY OF TORONTO   (Canada)

^f Xillix Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; EPIDERMIS HYPERPLASIA; GENE MUTATION; GENOTYPE; HAIR FOLLICLE; HISTOPATHOLOGY; HYPERKERATOSIS; KERATINOCYTE; MALNUTRITION; MORPHOGENESIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; FEMALE; HAIR FOLLICLE; HYPERPLASIA; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SKIN; SKIN ABNORMALITIES; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037309972     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie. R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Wash DC), 275: 1943-1947, 1997.
2. Liaw, D., Marsh,. D. J., Li, J., Dahia, P. L., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
3. Marsh, D. J., Dahia, P, L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
4. Hildenbrand. C., Burgdorf. W. H., and Lautenschlager, S. Cowden syndrome-diagnostic skin signs. Dermatology (Basel), 202: 362-366, 2001.
5. Nuss, D. D., Aeling, J. L., Clemons, D. E., and Weber. W. N. Multiple hamartoma syndrome (Cowden's disease). Arch. Dermatol., 114: 743-746, 1978.
6. Camisa, C., Bikowski. J. B., and McDonald, S. G. Cowden's disease. Association with squamous cell carcinoma of the tongue and perianal basal cell carcinoma, Arch. Dermatol., 120: 677-678, 1984.
7. Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., and Tonks, N. K. P-TEN. the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase, Proc. Natl. Acad. Sci., USA 94: 9052-9057, 1997.
8. Maehama, T., and Dixon. J. E. The tumor suppressor, PTEN/MMACI, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273: 13375-13378, 1998.
9. , Hu, P., Margolis, B., Skolnik, E. Y., Lammers, R., Ullrich, A., and Schlessinger, J. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell. Biol., 12: 981-990, 1992.
10. Ponzetto, C., Bardelli. A., Maina. F., Longati, P., Panayotou, G., Dhand, R., Waterfield, M. D., and Comoglio, P. M. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol. Cell. Biol., 13: 4600-4608, 1993.
11. Raffioni, S., and Bradshaw, R. A. Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells. Proc. Natl. Acad. Sci. USA, 89: 9121-9125, 1992.
12. Yamamoto. K., Lapetina, E. G., and Moxham, C. P. Insulin like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor. Endocrinology, 130: 1490-1498, 1992.
13. Fuchs, E. Epidermal differentiation. Curr. Opin. Cell Biol., 2: 1028-1035, 1990.
14. Fuchs, E. Epidermal differentiation: the bare essentials. J. Cell Biol., 111: 2807-2814, 1990.
15. Fuchs. E. Keratin genes, epidermal differentiation and animal models for the study of human skin diseases. Biochem. Soc. Trans., 19: 1112-1115, 1991.
16. Jones, P. H., and Watt, F. M. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell, 73: 713-724, 1993.
17. Wu, X., and Pandolfi, P. P. Mouse models for multistep tumorigenesis. Trends Cell Biol., 11: S2-S9, 2001.
18. Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., and Takeda, J. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J., 18: 4657-4668, 1999.
19. Yamamoto, T,. Kamata, N., Kawano, H., Shimizu. S., Kuroki, T., Toyoshima, K., Rikimaru, K., Nomura, N., Ishizaki, R., Pastan, I., et al. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res., 46: 414-416, 1986.
20. Rho, O., Bol, D. K., You, J., Beltran, L., Rupp, T., and DiGiovanni, J. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin. Mol. Carcinog., 17: 62-69, 1996.
21. Vassar, R., Hutton, M, E., and Fuchs, E. Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol. Cell. Biol., 12: 4643-4653, 1992.
22. Vassar, R., and Fuchs. E. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev., 5: 714-727, 1991.
23. Dominey, A, M., Wang, X. J., King, L. E., Jr., Nanney, L. B., Gagne, T. A., Sellheyer, K. Bundman, D. S., Longley, M. A., Rothnagel, J. A., Greenhalgh. D. A,. et al. Targeted overexpression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ., 4: 1071-1082, 1993.
24. Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F. M., Schlessinger, J., and Wagner, E. F. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell, 102: 211-220, 2000.
25. DiGiovanni, J., Bol, D. K., Wilker, E., Beltran, L., Carbajal, S., Moats, S., Ramirez, A., Jorcano, J., and Kiguchi, K. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res., 60: 1561-1570, 2000.
26. Greenhaigh, D. A., Rothnagel, J. A., Quintanilla, M. I., Orengo, C. C., Gagne, T. A., Bundman, D. S., Longley. M. A., and Roop, D. R. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v -Ha-ras oncogene. Mol. Carcinog., 7: 99-110, 1993.
27. Bol, D. K., Kiguchi, K., Gimenez-Conti, I., Rupp, T., and DiGiovanni, J, Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene, 14: 1725-1734, 1997.
28. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (Igf-1) and type 1 IGF receptor (Igflr). Cell, 75: 59-72, 1993.
29. Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., del Barco Barrantes, I., Ho, A., Wakeham, A., Itie, A., Khoo, W., Fukumoto, M., and Mak, T. W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol., 8: 1169-1178, 1998.
30. Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., and Mak, T. W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell., 95: 29-39, 1998.
31. Stambolic, V., Tsao, M. S., Macpherson, D., Suzuki, A., Chapman, W. B., and Mak, T. W. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res., 60: 3605-3611, 2000.
32. Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., and Parsons, R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA, 96: 1563-1568, 1999.
33. Segrelles, C., Ruiz, S., Perez, P., Murga, C., Santos, M., Budunova, I. V., Martinez, J., Larcher, F., Slaga, T. J., Gutkind. J. S., Jorcano. J. L., and Paramio, J. M. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene, 21: 53-64, 2002.
34. Tarutani, M., Itami, S., Okabe, M., Ikawa, M., Tezuka, T., Yoshikawa, K., Kinoshita, T., and Takeda, J. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc. Natl. Acad. Sci. USA, 94: 7400-7405, 1997.
35. Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M., Tsubata, T., Ohashi, P. S., Koyasu, S., Penninger, J. M., Nakano, T., and Mak, T. W. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity, 14: 523-534, 2001.
36. Byme, C., and Fuchs, E. Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol. Cell. Biol., 13: 3176-3190, 1993.
37. Murillas, R., Larcher, F., Conti, C. J., Santos, M., Ullrich, A., and Jorcano, J. L. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J., 14: 5216-5223, 1995.
38. Ramirez, A., Bravo, A., Jorcano, J. L., and Vidal, M. Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation, 58: 53-64, 1994.
39. Hardy, M. H. The secret life of the hair follicle. Trends Genet., 8: 55-61, 1992.
40. Shan, X., Czar, M. J., Bunnell, S. C., Liu, P., Liu, Y., Schwartzberg, P. L., and Wange, R. L. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol., 20: 6945-6957, 2000.
41. Backman, S. A., Stambolic. V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., Tsao, M. S., Shannon, P., Bolon, B., Ivy, G. O., and Mak, T. W. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet., 29: 396-403, 2001.
42. Trojan, J., Plotz, G., Brieger, A., Raedle, J., Meltzer, S. J., Wolter, M., and Zeuzem. S. Activation of a cryptic splice site of PTEN and loss of heterozygosity in benign skin lesions in Cowden disease. J. Investig. Dermatol., 117: 1650-1653, 2001.
43. Gat, U., DasGupta, R., Degenstein, L., and Fuchs, E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell., 95: 605-614, 1998.
44. Stenn, K. S., Combates, N. J., Eilertsen, K. J., Gordon, J. S., Pardinas, J. R., Parimoo, S., and Prouty, S. M. Hair follicle growth controls. Dermatol. Clin., 14: 543-558, 1996.
45. Persad, S., Troussard, A. A., McPhee, T. R., Mulholland, D. J., and Dedhar, S. Tumor suppressor PTEN inhibits nuclear accumulation of β-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol., 153: 1161-1174, 2001.
46. 1 cell cycle progression. J. Biol. Chem., 274: 22033-22040, 1999.